Pay in 4 interest-free payments of $6.29 Learn more
Ships within 48 hours · Estimated delivery Aug 19 - Aug 24
Head-to-head studies show people on tirzepatide lost an average 20.2% of their body weight compared to 13.7% with semaglutide over 72 weeks
Mounjaro/Zepbound (tirzepatide), approved dual GLP-1/GIP agonist for type 2 diabetes and obesity Recent Highlights: In April 2026, the FDA approved orforglipron (Foundayo), making it one of the first oral GLP-1 pills that can be taken any time of day and that has no food or water restrictions
.,
Is berberine really 'nature's Ozempic'
It failed to meet its primary endpoint conclusively
Fridays includes one-on-one behavior coaching, nutritional counseling with a dietitian, guided fitness sessions (including a Spanish option), a macro and weight tracker, and virtual community courses on metabolic health, stress management, and mindset
US$ 27.28
US$ 25.18
US$ 26.69
US$ 29.56
US$ 27.64
US$ 23.11
US$ 26.80
US$ 25.69
US$ 25.49
US$ 26.48
US$ 25.36
US$ 25.41
